News Focus
News Focus
Followers 24
Posts 3957
Boards Moderated 0
Alias Born 07/20/2006

Re: None

Thursday, 02/08/2007 10:37:05 AM

Thursday, February 08, 2007 10:37:05 AM

Post# of 19309
Read Me First - Patent Applications Update -

1 METHOD OF PURIFYING RECOMBINANT HUMAN ANTITHROMBIN TO ENHANCE THE VIRAL AND PRION SAFETY PROFILE
Inventor: ZIOMEK CAROL (US); HENDRY CHRISTOPHER (US) Applicant: GTC BIOTHERAPEUTICS INC (US); ZIOMEK CAROL (US); (+1)
EC: IPC: C07K14/81; G01N33/50; C07K14/81 (+1)
Publication info: WO2007014244 - 2007-02-01
http://v3.espacenet.com/textdoc?DB=EPODOC&IDX=WO2007014244&F=0

2 ERYTHROPOIETIN ANALOG-HUMAN SERUM ALBUMIN FUSION
Inventor: YOUNG MICHAEL W (US); MEADE HARRY M (US); (+1) Applicant: GTC BIOTHERAPEUTICS INC (US)
EC: C07K14/505; C07K14/765 IPC: A01K67/027; C12N15/62; A61K31/70 (+30)
Publication info: DK1088084T - 2007-01-29
http://v3.espacenet.com/textdoc?DB=EPODOC&IDX=DK1088084T&F=0

3 METHOD OF MAKING RECOMBINANT HUMAN ANTIBODIES FOR USE IN BIOSENSOR TECHNOLOGY Inventor: LIPOSKY GREGORY (US); OLSEN BYRON (US) Applicant: GTC BIOTHERAPEUTICS INC (US); LIPOSKY GREGORY (US); (+1)
EC: IPC: G01N33/53; C12P21/08; G01N33/53 (+1)
Publication info: WO2007001264 - 2007-01-04
http://v3.espacenet.com/textdoc?DB=EPODOC&IDX=WO2007001264&F=0

4 METHOD OF MAKING RECOMBINANT HUMAN ANTIBODIES FOR USE IN BIOSENSOR TECHNOLOGY
Inventor: LIPOSKY GREGORY (US); OLSEN BYRON V (US) Applicant: GTC BIOTHERAPEUTICS INC (US); LIPOSKY GREGORY (US); (+1)
EC: IPC: G01N33/50; G01N33/50
Publication info: WO2006138647 - 2006-12-28
http://v3.espacenet.com/textdoc?DB=EPODOC&IDX=WO2006138647&F=0

5 METHODS OF PROTEIN FRACTIONATION USING HIGH PERFORMANCE TANGENTIAL FLOW FILTRATION Inventor: PERRAULT MARK (US) Applicant: GTC BIOTHERAPEUTICS INC (US)
EC: IPC: A61K38/17; C07K1/34; A61K38/17 (+1)
Publication info: EP1732587 - 2006-12-20
http://v3.espacenet.com/textdoc?DB=EPODOC&IDX=EP1732587&F=0

6 METHOD OF PREVENTING FIBRIN CLOTS IN PULMONARY TISSUE THROUGH THE USE OF AEROSOLIZED ANTICOAGULANTS
Inventor: ENKHBAATAR PERENLEI (US); TRABER DANIEL L (US); (+1) Applicant: GTC BIOTHERAPEUTICS INC (US)
EC: A61K31/727; A61K38/36; (+1) IPC: A61K38/55; A61K31/727; A61K38/36 (+3)
Publication info: CA2557411 - 2005-09-09
http://v3.espacenet.com/textdoc?DB=EPODOC&IDX=CA2557411&F=0

7 USE OF AEROSOLIZED ANTITHROMBIN TO TREAT ACUTE LUNG INJURY Inventor: MURAKAMI KAZUNORI (US); ENKHBAATAR PERENLEI (US); (+4) Applicant: GTC BIOTHERAPEUTICS INC (US)
EC: A61K38/57 IPC: A61K38/48; A61K38/57; A61L9/04 (+3)
Publication info: EP1713500 - 2006-10-25
http://v3.espacenet.com/textdoc?DB=EPODOC&IDX=EP1713500&F=0

8 Improved methods for the fusion and activation of reconstructed embryos for use in nuclear transfer procedures in non-human mammals
Inventor: GAVIN WILLIAM G; MELICAN DAVID; (+1) Applicant: GTC BIOTHERAPEUTICS INC
EC: C12N15/87C1 IPC: A01K67/027; A61L27/00; C12N5/10 (+9)
Publication info: NZ533692 - 2006-09-29
http://v3.espacenet.com/textdoc?DB=EPODOC&IDX=NZ533692&F=0

9 A METHOD OF USING AN ANTI-CD137 ANTIBODY AS AN AGENT FOR RADIOIMMUNOTHERAPY OR RADIOIMMUNODETECTION
Inventor: STROME SCOTT E (US); SCHINDLER DANIEL (US); (+3) Applicant: GTC BIOTHERAPEUTICS INC (US); STROME SCOTT E (US); (+4)
EC: IPC: A61K39/395; C07K16/30; A61K39/395 (+1)
Publication info: WO2006088464 - 2006-08-24
http://v3.espacenet.com/textdoc?DB=EPODOC&IDX=WO2006088464&F=0

10 AN ANTI-CD137 ANTIBODY AS AN AGENT IN THE TREATEMENT OF CANCER AND GLYCOSYLATION VARIANTS THEREOF
Inventor: STROME SCOTT E (US); SCHINDLER DANIEL (US); (+2) Applicant: GTC BIOTHERAPEUTICS INC (US); STROME SCOTT E (US); (+3)
EC: IPC: C07K16/00; A61K39/395; C12P21/00 (+3)
Publication info: WO2006088447 - 2006-08-24
http://v3.espacenet.com/textdoc?DB=EPODOC&IDX=WO2006088447&F=0


Intellectual property - Thanks to Dew:

#msg-9174865 Production (“milk”) patent
#msg-7179529 Purification patent
#msg-13154218 Nuclear-transfer IP from Geron
#msg-4107224 IP license to PharmAthene (formerly Nexia) for Protexia
#msg-14110344 Government grant for Protexia



Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today